{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:47:54Z","timestamp":1790822874061,"version":"4.1.0"},"reference-count":54,"publisher":"Japanese Society of Toxicology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2021]]},"DOI":"10.2131\/jts.46.569","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:15:18Z","timestamp":1638310518000},"page":"569-587","source":"Crossref","is-referenced-by-count":6,"title":["Association between &lt;i&gt;in vitro&lt;\/i&gt; nuclear receptor-activating profiles of chemical compounds and their &lt;i&gt;in vivo&lt;\/i&gt; hepatotoxicity in rats"],"prefix":"10.2131","volume":"46","author":[{"given":"Susumu","family":"Kodama","sequence":"first","affiliation":[{"name":"Laboratory of Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Yoshii","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ota","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Reserach Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Yoshinari","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ono","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abe, T., Takahashi, M., Kano, M., Amaike, Y., Ishii, C., Maeda, K., Kudoh, Y., Morishita, T., Hosaka, T., Sasaki, T., Kodama, S., Matsuzawa, A., Kojima, H. and Yoshinari, K. (2017): Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid. Arch. Toxicol., <b>91<\/b>, 2365-2374.","DOI":"10.1007\/s00204-016-1888-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ankley, G.T., Bennett, R.S., Erickson, R.J., Hoff, D.J., Hornung, M.W., Johnson, R.D., Mount, D.R., Nichols, J.W., Russom, C.L., Schmieder, P.K., Serrrano, J.A., Tietge, J.E. and Villeneuve, D.L. (2010): Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem., <b>29<\/b>, 730-741.","DOI":"10.1002\/etc.34"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Boergesen, M., Pedersen, T.A., Gross, B., van Heeringen, S.J., Hagenbeek, D., Bindesb\u00f8ll, C., Caron, S., Lalloyer, F., Steffensen, K.R., Nebb, H.I., Gustafsson, J.A., Stunnenberg, H.G., Staels, B. and Mandrup, S. (2012): Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor \u03b1 in mouse liver reveals extensive sharing of binding sites. Mol. Cell. Biol., <b>32<\/b>, 852-867.","DOI":"10.1128\/MCB.06175-11"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Commerford, S.R., Vargas, L., Dorfman, S.E., Mitro, N., Rocheford, E.C., Mak, P.A., Li, X., Kennedy, P., Mullarkey, T.L. and Saez, E. (2007): Dissection of the insulin-sensitizing effect of liver X receptor ligands. Mol. Endocrinol., <b>21<\/b>, 3002-3012.","DOI":"10.1210\/me.2007-0156"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Corton, J.C., Peters, J.M. and Klaunig, J.E. (2018): The PPAR\u03b1-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. Arch. Toxicol., <b>92<\/b>, 83-119.","DOI":"10.1007\/s00204-017-2094-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Dawson, M.I. and Xia, Z. (2012): The retinoid X receptors and their ligands. Biochim. Biophys. Acta, <b>1821<\/b>, 21-56.","DOI":"10.1016\/j.bbalip.2011.09.014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"de Almeida, N.R. and Conda-Sheridan, M. (2019): A review of the molecular design and biological activities of RXR agonists. Med. Res. Rev., <b>39<\/b>, 1372-1397.","DOI":"10.1002\/med.21578"},{"key":"8","doi-asserted-by":"publisher","unstructured":"de Vries-van der Weij, J., de Haan, W., Hu, L., Kuif, M., Oei, H.L., van der Hoorn, J.W., Havekes, L.M., Princen, H.M., Romijn, J.A., Smit, J.W. and Rensen, P.C. (2009): Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein. Endocrinology, <b>150<\/b>, 2368-2375.","DOI":"10.1210\/en.2008-1540"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Delfosse, V., Grimaldi, M., Pons, J.L., Boulahtouf, A., le Maire, A., Cavailles, V., Labesse, G., Bourguet, W. and Balaguer, P. (2012): Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes. Proc. Natl. Acad. Sci. USA, <b>109<\/b>, 14930-14935.","DOI":"10.1073\/pnas.1203574109"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., Hauser, R., Prins, G.S., Soto, A.M., Zoeller, R.T. and Gore, A.C. (2009): Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev., <b>30<\/b>, 293-342.","DOI":"10.1210\/er.2009-0002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Esmon, C.T. (2005): The interactions between inflammation and coagulation. Br. J. Haematol., <b>131<\/b>, 417-430.","DOI":"10.1111\/j.1365-2141.2005.05753.x"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Evans, R.M. and Mangelsdorf, D.J. (2014): Nuclear receptors, RXR, and the big bang. Cell, <b>157<\/b>, 255-266.","DOI":"10.1016\/j.cell.2014.03.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Fang, M., Webster, T.F., Ferguson, P.L. and Stapleton, H.M. (2015): Characterizing the peroxisome proliferator-activated receptor (PPAR\u03b3) ligand binding potential of several major flame retardants, their metabolites, and chemical mixtures in house dust. Environ. Health Perspect., <b>123<\/b>, 166-172.","DOI":"10.1289\/ehp.1408522"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Feige, J.N., Gerber, A., Casals-Casas, C., Yang, Q., Winkler, C., Bedu, E., Bueno, M., Gelman, L., Auwerx, J., Gonzalez, F.J. and Desvergne, B. (2010): The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPAR\u03b1-dependent mechanisms. Environ. Health Perspect., <b>118<\/b>, 234-241.","DOI":"10.1289\/ehp.0901217"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Francis, G.A., Fayard, E., Picard, F. and Auwerx, J. (2003): Nuclear receptors and the control of metabolism. Annu. Rev. Physiol., <b>65<\/b>, 261-311.","DOI":"10.1146\/annurev.physiol.65.092101.142528"},{"key":"16","doi-asserted-by":"crossref","unstructured":"George, J., Tsuchishima, M. and Tsutsumi, M. (2019): Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death Dis., <b>10<\/b>, 18.","DOI":"10.1038\/s41419-018-1272-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Gronemeyer, H., Gustafsson, J.\u00c5. and Laudet, V. (2004): Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov., <b>3<\/b>, 950-964.","DOI":"10.1038\/nrd1551"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Gu, X. and Manautou, J.E. (2012): Molecular mechanisms underlying chemical liver injury. Expert Rev. Mol. Med., <b>14<\/b>, e4.","DOI":"10.1017\/S1462399411002110"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Hall, A.P., Elcombe, C.R., Foster, J.R., Harada, T., Kaufmann, W., Knippel, A., K\u00fcttler, K., Malarkey, D.E., Maronpot, R.R., Nishikawa, A., Nolte, T., Schulte, A., Strauss, V. and York, M.J. (2012): Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop. Toxicol. Pathol., <b>40<\/b>, 971-994.","DOI":"10.1177\/0192623312448935"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Kersten, S. and Stienstra, R. (2017): The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie, <b>136<\/b>, 75-84.","DOI":"10.1016\/j.biochi.2016.12.019"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Kliewer, S.A., Goodwin, B. and Willson, T.M. (2002): The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev., <b>23<\/b>, 687-702.","DOI":"10.1210\/er.2001-0038"},{"key":"22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tox.2018.12.001","author":"H. Kojima","year":"2019","unstructured":"Kojima, H., Takeuchi, S., Sanoh, S., Okuda, K., Kitamura, S., Uramaru, N., Sugihara, K. and Yoshinari, K. (2019): Profiling of bisphenol A and eight its analogues on transcriptional activity via human nuclear receptors. Toxicology, <b>413<\/b>, 48-55.","journal-title":"Toxicology","ISSN":"https:\/\/id.crossref.org\/issn\/0300-483X","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lalloyer, F., Pedersen, T.\u00c5., Gross, B., Lestavel, S., Yous, S., Vallez, E., Gustafsson, J.A., Mandrup, S., Fi\u00e9vet, C., Staels, B. and Tailleux, A. (2009): Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR\/LXR heterodimer in the liver. Arterioscler. Thromb. Vasc. Biol., <b>29<\/b>, 1488-1495.","DOI":"10.1161\/ATVBAHA.109.189506"},{"key":"24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tox.2004.09.008","author":"P.J. Lapinskas","year":"2005","unstructured":"Lapinskas, P.J., Brown, S., Leesnitzer, L.M., Blanchard, S., Swanson, C., Cattley, R.C. and Corton, J.C. (2005): Role of PPAR\u03b1 in mediating the effects of phthalates and metabolites in the liver. Toxicology, <b>207<\/b>, 149-163.","journal-title":"Toxicology","ISSN":"https:\/\/id.crossref.org\/issn\/0300-483X","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Ma, K., Saha, P.K., Chan, L. and Moore, D.D. (2006): Farnesoid X receptor is essential for normal glucose homeostasis. J. Clin. Invest., <b>116<\/b>, 1102-1109.","DOI":"10.1172\/JCI25604"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Mackowiak, B., Hodge, J., Stern, S. and Wang, H. (2018): The roles of xenobiotic receptors: beyond chemical disposition. Drug Metab. Dispos., <b>46<\/b>, 1361-1371.","DOI":"10.1124\/dmd.118.081042"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Maronpot, R.R., Yoshizawa, K., Nyska, A., Harada, T., Flake, G., Mueller, G., Singh, B., Ward, J.M. and Botts, S. (2010): Hepatic enzyme induction: histopathology. Toxicol. Pathol., <b>38<\/b>, 776-795.","DOI":"10.1177\/0192623310373778"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Moore, J.T., Collins, J.L. and Pearce, K.H. (2006): The nuclear receptor superfamily and drug discovery. ChemMedChem, <b>1<\/b>, 504-523.","DOI":"10.1002\/cmdc.200600006"},{"key":"29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/386407a0","author":"R. Mukherjee","year":"1997","unstructured":"Mukherjee, R., Davies, P.J., Crombie, D.L., Bischoff, E.D., Cesario, R.M., Jow, L., Hamann, L.G., Boehm, M.F., Mondon, C.E., Nadzan, A.M., Paterniti, J.R. Jr. and Heyman, R.A. (1997): Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature, <b>386<\/b>, 407-410.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Nakane, F., Kunieda, M., Shimizu, S., Kobayashi, Y., Akane, H., Akie, Y., Saito, A., Noguchi, M., Kadota, T. and Mitsumori, K. (2012): Twenty-six-week oral toxicity of diheptyl phthalate with special emphasis on its induction of liver proliferative lesions in male F344 rats. J. Toxicol. Sci., <b>37<\/b>, 527-537.","DOI":"10.2131\/jts.37.527"},{"key":"31","doi-asserted-by":"publisher","unstructured":"Okamura, M., Shizu, R., Abe, T., Kodama, S., Hosaka, T., Sasaki, T. and Yoshinari, K. (2020): PXR Functionally Interacts with NF-\u03baB and AP-1 to Downregulate the Inflammation-Induced Expression of Chemokine CXCL2 in Mice. Cells, <b>9<\/b>, 2296.","DOI":"10.3390\/cells9102296"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Paguio, A., Stecha, P., Wood, K.V. and Fan, F. (2010): Improved dual-luciferase reporter assays for nuclear receptors. Curr. Chem. Genomics, <b>4<\/b>, 43-49.","DOI":"10.2174\/1875397301004010043"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Pawlak, M., Lefebvre, P. and Staels, B. (2015): Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J. Hepatol., <b>62<\/b>, 720-733.","DOI":"10.1016\/j.jhep.2014.10.039"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Pinaire, J.A. and Reifel-Miller, A. (2007): Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome. PPAR Res., <b>2007<\/b>, 94156.","DOI":"10.1155\/2007\/94156"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Ploton, M., Mazuy, C., Gheeraert, C., Dubois, V., Berthier, A., Dubois-Chevalier, J., Mar\u00e9chal, X., Bantubungi, K., Diemer, H., Cianf\u00e9rani, S., Strub, J.M., Helleboid-Chapman, A., Eeckhoute, J., Staels, B. and Lefebvre, P. (2018): The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis. J. Hepatol., <b>69<\/b>, 1099-1109.","DOI":"10.1016\/j.jhep.2018.06.022"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Pollinger, J., Gellrich, L., Schierle, S., Kilu, W., Schmidt, J., Kalinowsky, L., Ohrndorf, J., Kaiser, A., Heering, J., Proschak, E. and Merk, D. (2019): Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation. J. Med. Chem., <b>62<\/b>, 2112-2126.","DOI":"10.1021\/acs.jmedchem.8b01848"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Repa, J.J., Turley, S.D., Lobaccaro, J.A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R.A., Dietschy, J.M. and Mangelsdorf, D.J. (2000): Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science, <b>289<\/b>, 1524-1529.","DOI":"10.1126\/science.289.5484.1524"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Sakuratani, Y., Zhang, H.Q., Nishikawa, S., Yamazaki, K., Yamada, T., Yamada, J., Gerova, K., Chankov, G., Mekenyan, O. and Hayashi, M. (2013): Hazard Evaluation Support System (HESS) for predicting repeated dose toxicity using toxicological categories. SAR QSAR Environ. Res., <b>24<\/b>, 351-363.","DOI":"10.1080\/1062936X.2013.773375"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Shah, I., Houck, K., Judson, R.S., Kavlock, R.J., Martin, M.T., Reif, D.M., Wambaugh, J. and Dix, D.J. (2011): Using nuclear receptor activity to stratify hepatocarcinogens. PLoS One, <b>6<\/b>, e14584.","DOI":"10.1371\/journal.pone.0014584"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Shimizu, Y., Sasaki, T., Yonekawa, E., Yamazaki, H., Ogura, R., Watanabe, M., Hosaka, T., Shizu, R., Takeshita, J.I. and Yoshinari, K. (2021): Association of CYP1A1 and CYP1B1 inhibition in <i>in vitro<\/i> assays with drug-induced liver injury. J. Toxicol. Sci., <b>46<\/b>, 167-176.","DOI":"10.2131\/jts.46.167"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Smith, S.A., Travers, R.J. and Morrissey, J.H. (2015): How it all starts: initiation of the clotting cascade. Crit. Rev. Biochem. Mol. Biol., <b>50<\/b>, 326-336.","DOI":"10.3109\/10409238.2015.1050550"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Standeven, A.M., Thacher, S.M., Yuan, Y.D., Escobar, M., Vuligonda, V., Beard, R.L. and Chandraratna, R.A. (2001): Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents. Biochem. Pharmacol., <b>62<\/b>, 1501-1509.","DOI":"10.1016\/S0006-2952(01)00803-6"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Stofan, M. and Guo, G.L. (2020): Bile Acids and FXR: Novel Targets for Liver Diseases. Front. Med. (Lausanne), <b>7<\/b>, 544.","DOI":"10.3389\/fmed.2020.00544"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Sui, Y., Ai, N., Park, S.H., Rios-Pilier, J., Perkins, J.T., Welsh, W.J. and Zhou, C. (2012): Bisphenol A and its analogues activate human pregnane X receptor. Environ. Health Perspect., <b>120<\/b>, 399-405.","DOI":"10.1289\/ehp.1104426"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Tanaka, N., Aoyama, T., Kimura, S. and Gonzalez, F.J. (2017): Targeting nuclear receptors for the treatment of fatty liver disease. Pharmacol. Ther., <b>179<\/b>, 142-157.","DOI":"10.1016\/j.pharmthera.2017.05.011"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Uehara, T., Kiyosawa, N., Hirode, M., Omura, K., Shimizu, T., Ono, A., Mizukawa, Y., Miyagishima, T., Nagao, T. and Urushidani, T. (2008): Gene expression profiling of methapyrilene-induced hepatotoxicity in rat. J. Toxicol. Sci., <b>33<\/b>, 37-50.","DOI":"10.2131\/jts.33.37"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Villeneuve, D.L., Crump, D., Garcia-Reyero, N., Hecker, M., Hutchinson, T.H., LaLone, C.A., Landesmann, B., Lettieri, T., Munn, S., Nepelska, M., Ottinger, M.A., Vergauwen, L. and Whelan, M. (2014): Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol. Sci., <b>142<\/b>, 312-320.","DOI":"10.1093\/toxsci\/kfu199"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Wang, B. and Tontonoz, P. (2018): Liver X receptors in lipid signalling and membrane homeostasis. Nat. Rev. Endocrinol., <b>14<\/b>, 452-463.","DOI":"10.1038\/s41574-018-0037-x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Wang, H., Chen, J., Hollister, K., Sowers, L.C. and Forman, B.M. (1999): Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. Mol. Cell, <b>3<\/b>, 543-553.","DOI":"10.1016\/S1097-2765(00)80348-2"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Sasaki, T., Takeshita, J.I., Kushida, M., Shimizu, Y., Oki, H., Kitsunai, Y., Nakayama, H., Saruhashi, H., Ogura, R., Shizu, R., Hosaka, T. and Yoshinari, K. (2020): Application of cytochrome P450 reactivity on the characterization of chemical compounds and its association with repeated-dose toxicity. Toxicol. Appl. Pharmacol., <b>388<\/b>, 114854.","DOI":"10.1016\/j.taap.2019.114854"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Waxman, D.J. (1999): P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys., <b>369<\/b>, 11-23.","DOI":"10.1006\/abbi.1999.1351"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Wolf, C.J., Takacs, M.L., Schmid, J.E., Lau, C. and Abbott, B.D. (2008): Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths. Toxicol. Sci., <b>106<\/b>, 162-171.","DOI":"10.1093\/toxsci\/kfn166"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Woods, C.G., Heuvel, J.P. and Rusyn, I. (2007): Genomic profiling in nuclear receptor-mediated toxicity. Toxicol. Pathol., <b>35<\/b>, 474-494.","DOI":"10.1080\/01926230701311351"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Yoshinari, K. (2019): Role of nuclear receptors PXR and CAR in xenobiotic-induced hepatocyte proliferation and chemical carcinogenesis. Biol. Pharm. Bull., <b>42<\/b>, 1243-1252.","DOI":"10.1248\/bpb.b19-00267"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/46\/12\/46_569\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T04:05:48Z","timestamp":1638590748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/46\/12\/46_569\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.46.569","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}